By early 2026, FDA had publicly announced enforcement actions against multiple compounded GLP-1 telehealth platforms, and in April 2026 formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list - with a public comment period running through June 2026
These peptides offer pharmacology comparable to native peptides and improved effectiveness compared to similarly modified selective GLP- 1 agonists
Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF
The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil
These expansions will eventually relieve shortages, but only after long lead times
SAN DIEGO GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, according to results presented here